Furthermore, our PPI network analysis identified that 35 significant nodes and nine genes participate in the PI3K-Akt signaling pathway, which confirmed data from a previous study, indicating potential therapeutic targets for ovarian cancer (Li, Zeng & Shen, 2014). This evidence concerns the gene AKT1 and ovarian carcinoma.